A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study-Reference-Cited by-同舟云学术

A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study

Published:2021-02-02 Issue:3 Volume:38 Page:1536-1551
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Mitsikostas Dimos D.,Doskas Triantafyllos,Gkatzonis Stylianos,Fakas Nikolaos,Maltezou Maria,Papadopoulos Dimitrios,Gourgioti Rania,Mitsias Panayiotis

Funder

Genesis Pharma

Biogen Idec International GmbH

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-020-01606-5.pdf

Reference55 articles.

1. Albrecht P, Bjørnå IK, Brassat D, Farrell R, Feys P, Hobart J, et al. Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting. Ther. Adv. Neurol. Disord. 2018;11:1–8.

2. Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J. Neurol. Sci. 2009;277(S1):S37–41.

3. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Mult Scler. 2001;7:340–4.

4. Rodriguez-Leal FA, Haase R, Akgün K, Eisele J, Proschmann U, Schultheiss T, et al. Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting. Ther Adv Chronic Dis. 2019;10:1–11.

5. Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler. 2006;12(4):367–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Fatigue Symptoms in the Post-COVID Syndrome With Amifampridine: A Collective Casuistry With Double-Blind Discontinuation Trials;Cureus;2024-01-25

2. The “Journey” of Patients with Multiple Sclerosis in Greece—A Qualitative Study;Psychology;2024

3. Investigating the safety of Fampridine in patients with different stages of multiple sclerosis;2023-06-29

4. The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial;Current Journal of Neurology;2023-01-17

5. The quality of life in patients with multiple sclerosis – Association with depressive symptoms and physical disability: A prospective and observational study;Frontiers in Psychology;2023-01-06